Partner Headlines - CLSN

  1. Morning Market Losers

    Benzinga
  2. Celsion Announces Potent, Durable Preclinical Lung Expression ...

    Benzinga
  3. Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase ...

    Benzinga
  4. Earnings Scheduled For May 11, 2015

    Benzinga
  5. Morning Market Gainers

    Benzinga
  6. UPDATE: Celsion Slightly Falls Back Following Treatment News

    Benzinga
  7. Celsion Jumps On Interim Data On Cancer Drug

    Benzinga
  8. Morning Market Gainers

    Benzinga
  9. Benzinga's Top Initiations

    Benzinga
  10. Celsion Presents Preclinical Data For Its TheraSilence Platform ...

    Benzinga
  11. Morning Market Movers

    Benzinga
  12. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  13. Celsion to Present Updated Overall Survival Results from HEAT ...

    Benzinga
  14. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly ...

    Benzinga
  15. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  16. Celsion Announces $15M At-The-Market Registered Direct Offering ...

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Celsion Presents Combined Clinical Data from Two Phase I Trials ...

    Benzinga
  19. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan ...

    Benzinga
  20. Stocks Hitting 52-Week Lows

    Benzinga
  21. Celsion Halted Wednesday, Says Will Host Conference Call Jan ...

    Benzinga
  22. Option Speculators Circle Celsion

    SchaeffersResearch
  23. Stocks Hitting 52-Week Highs

    Benzinga
  24. UPDATE: Dawson James Initiates Celsion at Market Outperform on ...

    Benzinga
  25. Celsion Corp Says Continuing Phase 2 Study

    Benzinga
  26. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 ...

    GuruFocus
  27. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga
  28. Health Care Sector Wrap

    FoxBusiness
  29. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness
  30. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch
  31. Celsion Announces Collaboration With the University of Oxford ...

    Benzinga
  32. Celsion Announces Resubmission With Philips Healthcare of Combined ...

    Benzinga
  33. Celsion Announces ThermoDox Commercial Supply Agreement With ...

    Benzinga
  34. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga
  35. Celsion Completes Consultative Review Process With EMA for Phase ...

    Benzinga
  36. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  37. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus
Trading Center